BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06797635-completion@plaintrial.com
DTSTAMP:20261027T051054Z
DTSTART;VALUE=DATE:20341231
SUMMARY:Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Antica
 ncer Agents in Participants With High-Risk Early-Stage Triple-Negative or 
 Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010\, 
 HERTHENA-Breast-03) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06797635
URL:https://plaintrial.com/trial/NCT06797635
END:VEVENT
END:VCALENDAR